日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Creating ultra-high linolenic acid camelina by co-expressing AtFAD2sm with synonymous mutations and BnFAD3 in the fae1 mutant

通过在 fae1 突变体中共表达具有同义突变的 AtFAD2sm 和 BnFAD3,创造出超高亚麻酸含量的亚麻荠。

Li, Na; Liu, Xiangling; Chen, Yangyang; Wang, Hailan; Zhao, Yingdong; Du, Chang; Lu, Chaofu; Zhang, Meng

A Phase I Study of Nilotinib in Combination with Paclitaxel in Patients with Advanced Solid Tumors

尼洛替尼联合紫杉醇治疗晚期实体瘤患者的I期研究

Shin, Sarah J; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Miller, Sarah B; Johnson, Barry C; Anderson, Larry; Rubinstein, Larry; Miller, Brandon; Wilsker, Deborah F; Ferry-Galow, Katherine V; Piekarz, Richard; Zlott, Jennifer; Hogu, Murielle; Juwara, Lamin; Krushkal, Julia; Konaté, Mariam; Palmisano, Alida; Zhao, Yingdong; Collins, Jerry; Parchment, Ralph E; Doroshow, James H; Chen, Alice P

Allelic expression patterns of imprinted and non-imprinted genes in cancer cell lines from multiple histologies

多种组织学类型癌细胞系中印记基因和非印记基因的等位基因表达模式

Krushkal, Julia; Jensen, Travis L; Wright, George; Zhao, Yingdong

Preclinical NCI-MPACT: prospective modeling of the mutation-based NCI-MPACT clinical trial therapeutic strategy in patient-derived xenograft models.

NCI-MPACT 临床前研究:在患者来源的异种移植模型中对基于突变的 NCI-MPACT 临床试验治疗策略进行前瞻性建模

Evrard Yvonne A, Alcoser Sergio Y, Mullendore Michael, Chen Li, Lih Chih-Jian, Kannan Vishnuprabha Rahul, Datta Vivekananda, Dutko Lindsay, Jiwani Shahanawaz, Rubinstein Lawrence V, Zhao Yingdong, Williams P Mickey, Palmisano Alida, Kuhlmann Laura, Simpson Mel, Kummar Shivaani, Das Biswajit, Karlovich Chris, Polley Eric, Li Ming-Chung, Chen Alice P, Hollingshead Melinda G, Doroshow James H

Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts

胰腺癌吉西他滨耐药性的深入研究:与代谢重编程和TP53致病性在患者来源异种移植模型中的关联

Konaté, Mariam M; Krushkal, Julia; Li, Ming-Chung; Chen, Li; Kotliarov, Yuri; Palmisano, Alida; Pauly, Rini; Xie, Qian; Williams, P Mickey; McShane, Lisa M; Zhao, Yingdong

Retraction Note: Lactate dehydrogenase D serves as a novel biomarker for prognosis and immune infiltration in lung adenocarcinoma

撤稿声明:乳酸脱氢酶D可作为肺腺癌预后和免疫浸润的新型生物标志物

Zhang, Yu; Zhang, Tianyi; Zhao, Yingdong; Wu, Hongdi; Zhen, Qiang; Zhu, Suwei; Hou, Shaoshuai

Association of changes in expression of HDAC and SIRT genes after drug treatment with cancer cell line sensitivity to kinase inhibitors

药物治疗后 HDAC 和 SIRT 基因表达变化与癌细胞系对激酶抑制剂敏感性的关联

Krushkal, Julia; Zhao, Yingdong; Roney, Kyle; Zhu, Weimin; Brooks, Alan; Wilsker, Deborah; Parchment, Ralph E; McShane, Lisa M; Doroshow, James H

Quantitative Investigation of FAD2 Cosuppression Reveals RDR6-Dependent and RDR6-Independent Gene Silencing Pathways

FAD2共抑制的定量研究揭示了RDR6依赖性和RDR6非依赖性基因沉默通路

Chen, Yangyang; Ku, Hangkai; Zhao, Yingdong; Du, Chang; Zhang, Meng

Revisiting Concurrent Radiation Therapy, Temozolomide, and the Histone Deacetylase Inhibitor Valproic Acid for Patients with Glioblastoma-Proteomic Alteration and Comparison Analysis with the Standard-of-Care Chemoirradiation

重新审视同步放疗、替莫唑胺和组蛋白去乙酰化酶抑制剂丙戊酸治疗胶质母细胞瘤患者的疗效——蛋白质组学改变及与标准化疗放疗的比较分析

Krauze, Andra V; Zhao, Yingdong; Li, Ming-Chung; Shih, Joanna; Jiang, Will; Tasci, Erdal; Cooley Zgela, Theresa; Sproull, Mary; Mackey, Megan; Shankavaram, Uma; Tofilon, Philip; Camphausen, Kevin

Immunomodulatory Activity and Its Mechanisms of Two Polysaccharides from Poria cocos

两种茯苓多糖的免疫调节活性及其机制

Wuxia Zhang, Jiaqi He, Danping Zheng, Panpan Zhao, Yingdong Wang, Jinzhong Zhao, Peng Li